Dyne Therapeutics, Inc.
Last 30 daysInsiders bought $40K · 1 buyer, led by Brian S. Posner (Director) with $40K. Sales: $247.78K by 3 insiders.
Showing the first 6 of 9 trades on this page.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Stock option (right to buy)
Derivative security · not the ordinary share price.
The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.
Director
Common Stock
The filing reports a zero transaction price for this gift. It does not establish the market value of the gift.
| Reporting insider | Security / transaction | Amount / price | Value | Traded / disclosed | Source |
|---|---|---|---|---|---|
| Director | Stock option (right to buy)Grant or award | Derivative units57,463Award · no purchase price | Non-cash award | Jun 22Filed Jun 23 · 1d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Stock option (right to buy)Grant or award | Derivative units35,152Award · no purchase price | Non-cash award | Jun 5Filed Jun 9 · 4d later | SEC filing |
| Director | Common StockGift | 53,625Gift · no purchase price | Not a purchase | Apr 24Filed Apr 28 · 4d later | SEC filing |
This reflects the filings imported so far, not a complete trading history.
$79,200 of common-equity purchase value after transaction-age decay across 180 days.
1 distinct reporting-owner group(s). Joint rows count once; identity is not proof of discretion.
At least one row increased reported same-security holdings by 10% or established a new reported position; indirect interests may overlap.
This score describes qualifying insider purchases at issuer level. Read the methodology
Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.
Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.
